Biography

Prof. Mehmet Kanbay

Division of Nephrology

Koc University School of Medicine, Turkey


Email: [email protected], [email protected]


Qualifications

2000 M.D., Istanbul University, Turkey

1993 B.Sc., Yamanlar Science School, Turkey


Publications (Selected)

  1. Kanbay, M., Ozbek, L., Guldan, M., Abdel-Rahman, S. M., Narin, A. E., & Ortiz, A. (2025). Ultra-processed foods and cardio-kidney-metabolic syndrome: A review of recent evidence. European Journal of Internal Medicine.
  2. Senturk, B. G., Gurses, B., Soyturk, C., Copur, S., Incir, S., Siriopol, D., ... & Kanbay, M. (2025). Effects of plant-based diet on metabolic parameters, liver and kidney steatosis: a prospective interventional open-label study. British Journal of Nutrition, 133(3), 289-298.
  3. Zoccali, C., Mallamaci, F., Kanbay, M., Tuttle, K. R., Kotanko, P., De Caterina, R., ... & Mancia, G. (2025). The Autonomic Nervous System and Inflammation in Chronic Kidney Disease. Nephrology Dialysis Transplantation, gfaf020.
  4. Burlacu, A., Kuwabara, M., Brinza, C., & Kanbay, M. (2025). Key Updates to the 2024 ESC Hypertension Guidelines and Future Perspectives. Medicina, 61(2), 193.
  5. Kanbay, M., Copur, S., Guldan, M., Ozbek, L., Mallamaci, F., & Zoccali, C. (2025). Glucagon and glucagon‐like peptide‐1 dual agonist therapy: A possible future towards fatty kidney disease. European Journal of Clinical Investigation, 55(1), e14330.
  6. Kuwabara, M., Ae, R., Kosami, K., Kanbay, M., Andres-Hernando, A., Hisatome, I., & Lanaspa, M. A. (2024). Current updates and future perspectives in uric acid research, 2024. Hypertension Research, 1-7.
  7. Theodorakopoulou, M., Ortiz, A., Fernandez-Fernandez, B., Kanbay, M., Minutolo, R., & Sarafidis, P. A. (2024). Guidelines for the management of hypertension in CKD patients: where do we stand in 2024?. Clinical Kidney Journal, 17(Supplement_2), 36-50.
  8. Kuwabara, M., Hisatome, I., Ae, R., Kosami, K., Aoki, Y., Andres-Hernando, A., ... & Lanaspa, M. A. (2024). Hyperuricemia, A New Cardiovascular Risk. Nutrition, Metabolism and Cardiovascular Diseases, 103796.
  9. Ozbek, L., Abdel-Rahman, S. M., Unlu, S., Guldan, M., Copur, S., Burlacu, A., ... & Kanbay, M. (2024). Exploring Adiposity and Chronic Kidney Disease: Clinical Implications, Management Strategies, Prognostic Considerations. Medicina, 60(10), 1668.
  10. Eknoyan, G., Lameire, N., Eckardt, K., Kasiske, B., Wheeler, D., Levin, A., ... & Coresh, J. J. K. I. (2013). KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney int, 3(1), 5-14.
  11. Kanbay, M., Siriopol, D., Copur, S., Hasbal, N. B., Güldan, M., Kalantar-Zadeh, K., ... & von Haehling, S. (2024). Effect of Bimagrumab on body composition: a systematic review and meta-analysis. Aging Clinical and Experimental Research, 36(1), 185.
  12. Kanbay, M., Brinza, C., Ozbek, L., Guldan, M., Sisman, U., Copur, S., ... & Covic, A. (2024). The association between klotho and kidney and cardiovascular outcomes: a comprehensive systematic review and meta-analysis. Clinical Kidney Journal, 17(9), sfae255.
  13. Kanbay, M., Copur, S., Bakir, C. N., Covic, A., Ortiz, A., & Tuttle, K. R. (2024). Glomerular hyperfiltration as a therapeutic target for CKD. Nephrology Dialysis Transplantation, 39(8), 1228-1238.
  14. Kanbay, M., Copur, S., Yildiz, A. B., Tanriover, C., Mallamaci, F., & Zoccali, C. (2024). Physical exercise in kidney disease: a commonly undervalued treatment modality. European Journal of Clinical Investigation, 54(2), e14105.
  15. Kanbay, M., Copur, S., Siriopol, D., Yildiz, A. B., Gaipov, A., Van Raalte, D. H., & Tuttle, K. R. (2023). Effect of tirzepatide on blood pressure and lipids: a meta‐analysis of randomized controlled trials. Diabetes, Obesity and Metabolism, 25(12), 3766-3778.
  16. Sarafidis, P., Iatridi, F., Ferro, C., Alexandrou, M. E., Fernandez-Fernandez, B., Kanbay, M., ... & Ortiz, A. (2023). Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA). Clinical Kidney Journal, 16(11), 1885-1907.
  17. Kanbay, M., Tanriover, C., Copur, S., Peltek, I. B., Mutlu, A., Mallamaci, F., & Zoccali, C. (2023). Social isolation and loneliness: Undervalued risk factors for disease states and mortality. European Journal of Clinical Investigation, 53(10), e14032.
  18. Kanbay, M., Ureche, C., Copur, S., Covic, A. M., Tanriover, C., Esen, B. H., ... & Covic, A. (2023). Kidney transplantation: a possible solution to obstructive sleep apnea in patients with end-stage kidney disease. Sleep and Breathing, 27(5), 1667-1675.
  19. Kanbay, M., Copur, S., Tanriover, C., Ucku, D., & Laffin, L. (2023). Future treatments in hypertension: Can we meet the unmet needs of patients?. European Journal of Internal Medicine, 115, 18-28.
  20. Sánchez-Lozada, L. G., Madero, M., Mazzali, M., Feig, D. I., Nakagawa, T., Lanaspa, M. A., ... & Johnson, R. J. (2023). Sugar, salt, immunity and the cause of primary hypertension. Clinical kidney journal, 16(8), 1239-1248.


Profile Details

WoS ResearcherID: L-6277-2019

https://www.linkedin.com/in/mehmet-kanbay-864ab4208/

https://scholar.google.com/citations?user=l__HSVUAAAAJ&hl=tr

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top